한글목차

세계 입자선 치료 시장의 미래는 치료용 시장과 연구용 시장에 기회가 있어 유망한 것으로 평가되고 있습니다. 세계 입자선 치료 시장은 2025-2031년 7.8%의 연평균 복합 성장률(CAGR)로 2031년까지 약 13억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 암 발병률 증가, 임상 연구에서의 입자선 치료의 급격한 증가, 전 세계 입자선 치료 시설 증가입니다.

• Lucintel의 예측에 따르면, 유형별로는 양성자선이 예측 기간 동안 가장 높은 성장을 보일 것으로 예측됩니다.
• 용도별로는 치료용이 예측 기간 동안 가장 높은 성장세를 보일 것으로 예측됩니다.
• 지역별로는 북미가 예측 기간 동안 가장 규모가 큰 지역으로 남을 것으로 예측됩니다.

입자선 치료 시장의 전략적 성장 기회

입자선 치료 시장에는 전략적 성장 기회를 제공하는 몇 가지 응용 분야가 있습니다. 여기에는 기술 발전, 암 발병률 증가, 더 나은 치료 옵션의 필요성 등이 포함됩니다. 따라서 시장을 크게 확대하는 동시에 환자의 치료 결과를 개선하기 위해서는 이러한 분야에 집중하는 것이 중요합니다.

• 소아암 치료: 입자선 치료에서 가장 빠르게 성장하는 분야 중 하나는 소아암 치료입니다. 특히 소아의 경우 양성자 치료는 매우 정확한 결과를 가져오고 부작용을 최소화할 수 있습니다. 따라서 인식의 향상과 방사선 시설의 존재로 인해 다양한 형태의 입자선 치료를 제공하는 소아용 센터에 대한 수요가 증가하고 있습니다. 이 기회는 소아 친화적인 프로토콜에 대한 투자를 촉진하고 소아암을 치료하는 새로운 방법에 대한 연구를 촉진합니다.
• 두경부암 치료: 두경부암은 입자선 치료의 주요 성장 분야입니다. 두경부암은 척수나 뇌와 같은 민감한 장기에 근접해 있기 때문에 치료 과정에서 정밀도가 요구됩니다. 이러한 경우, 주변 조직이 크게 손상되지 않기 때문에 입자선 치료는 특정 신체 부위만을 표적으로 하는 완벽한 접근법이 될 수 있습니다. 그 결과, 두경부암은 점점 더 특수한 입자선 치료를 필요로 하고 있습니다.
• 재발암 치료: 입자선 치료는 재발암 치료에 매우 유망합니다. 재발성 종양 환자는 이전 방사선 노출로 인해 치료 옵션이 제한되어 있는 경우가 많습니다. 입자선 치료는 주변의 건강한 조직을 보존하면서 종양에만 작용하는 안전한 치료법으로 여겨져 왔습니다. 따라서 이러한 특징이 재발성 암 환자들에 대한 채택을 촉진하고 있으며, 이는 이 시장에서 전략적 성장 기회로 작용하고 있습니다.
• 면역요법과의 통합: 입자선 치료와 면역요법의 융합은 암 치료의 새로운 개발 분야입니다. 이 조합은 종양에 대한 면역반응을 현저하게 증가시켜 더 나은 치료 결과를 가져옵니다. 입자선 치료와 면역치료의 시너지 효과에 대한 임상시험이 진행되고 있으며, 연구 개발이 진행 중입니다. 따라서 이러한 융합은 새로운 유형의 항암제를 만들고 입자선 치료를 더 많은 시장으로 확대할 수 있는 좋은 기회가 될 것입니다.
• 폐암 치료: 폐암 치료의 경우, 종양에 대처하기 매우 어려운 부위이기 때문에 입자선 치료가 주목받고 있습니다. 입자선 치료는 폐 조직의 다른 부분에 해를 끼치지 않고 정확한 라돈 선량을 제공하기 때문에 이 질병 과정과 관련된 부작용을 최소화할 수 있기 때문에 여전히 최선의 선택 중 하나입니다. 또한, 폐암 발생률에 대한 전 세계 통계 증가는 이 시장 세분화에서 성장성이 기대되는 주요 분야 중 하나로 자리매김하여 고도의 개입을 요구하고 있습니다.

입자선 치료 시장의 미래는 암 치료의 중요한 요구에 대응하는 이러한 전략적 성장 기회를 통해 만들어지고 있습니다. 이러한 용도에 집중함으로써 시장은 범위를 확장하고 환자 결과를 개선할 수 있으며, 입자선 치료는 현대 종양학의 초석이 될 수 있습니다.

입자선 치료 시장 성장 촉진요인 및 과제

입자선 치료 시장은 기술 발전, 경제적 고려사항, 규제 이슈 등 여러 요인의 영향을 받고 있습니다. 이는 효과적인 암 치료의 제공뿐만 아니라 시장 성장에도 큰 영향을 미칩니다. 입자선 치료의 역동적인 환경을 헤쳐나가기 위해 이해관계자들은 이러한 촉진요인과 과제를 이해해야 합니다.

입자선 치료 시장을 이끄는 요인은 다음과 같습니다.

1. 기술 개발: 입자선 치료의 주요 촉진요인으로는 펜슬 빔 스캐닝과 적응증 치료 등의 기술 발전이 있습니다. 이러한 발전을 통해 부작용을 최소화하면서 치료의 정확도를 높일 수 있어 치료 성공률의 향상으로 이어집니다. 이처럼 시간이 지남에 따라 기술이 입자선 치료의 보급을 촉진하여 전 세계 암 치료의 유력한 대안이 될 것으로 예측됩니다.

2. 암 발생률 증가: 입자선 치료 시장의 주요 촉진요인은 전 세계 암 발병률 증가입니다. 새로운 사례가 계속 발생함에 따라 보다 효과적인 첨단 치료법이 요구되고 있습니다. 이에 따라 입자선 치료가 다양한 유형의 암에 대한 더 나은 치료법으로 전 세계적으로 받아들여지고 있으며, 이는 이 시장을 주도하고 있습니다.

3. 정부 지원 및 자금 조달: 정부의 지원과 자금은 입자선 치료 시장 개척의 중요한 촉진요인입니다. 정부는 연구 보조금 제공과 함께 입자 시설 개발에 투자하고 있습니다. 그 중요성을 간과할 수 없습니다. 왜냐하면, 이는 가격의 경제성을 촉진하고 접근성을 향상시켜 이 특수 산업이 확대되고 더 많은 환자들이 이 기술의 혜택을 누릴 수 있도록 하기 때문입니다.

4. 관심 증가 및 보급: 입자선 치료와 관련된 이점에 대한 인식이 높아짐에 따라 전 세계 여러 지역에서 입자선 치료의 이용이 증가하고 있습니다. 환자와 의료 서비스 제공업체 모두 기존 방사선 기술에 비해 입자선 치료의 장점에 대해 더 많이 알게 되면서 입자선 센터에 대한 수요가 증가하여 이 시장의 성장을 주도하고 있습니다.

5. 신흥 시장에서의 확대: 세계 입자선 치료 시장의 원동력 중 하나는 신흥 시장, 특히 아시아에서의 확대입니다. 입자선 치료는 암 환자 증가와 의료비 지출 증가로 인해 중국, 인도 등의 국가에서 빠르게 도입되고 있습니다. 그 결과, 더 많은 사람들이 입자선 치료의 혜택을 누릴 수 있게 되었고, 입자선 치료는 세계적인 현상이 되었습니다.

입자선 치료 시장의 과제는 다음과 같습니다.

1. 치료비 상승: 치료비 상승은 입자선 치료 시장이 직면한 큰 과제 중 하나입니다. 입자선 치료와 관련된 고가의 기계 및 기타 장비로 인해 많은 환자, 특히 저소득층은 접근하기 어려운 실정입니다. 이러한 어려움은 이 기술의 광범위한 채택에 큰 걸림돌이 되어 시장 성장 전망을 제한하고 있습니다.

2. 시설의 가용성 제약: 또 다른 중요한 과제는 입자선 치료 센터에 대한 접근성이 제한적이라는 점입니다. 이러한 시설이 증가하고 있지만, 수요에 비해 아직 부족한 실정입니다. 그 결과, 많은 환자들, 특히 농촌이나 인구가 적은 지역에 거주하는 환자들은 이용 가능한 시설이 부족하여 입자선 치료를 받을 수 없으며, 이는 기업의 성장을 가속하는 새로운 시장 진입을 방해하고 있습니다.

3. 규제 및 상환 문제: 입자선 치료 시장은 규제 및 상환 문제라는 장애물에 직면해 있습니다. 각국의 복잡한 규제와 정책, 상환에 대한 편차는 신기술의 채택을 지연시키는 요인으로 작용합니다. 또한, 이러한 문제들은 환자들에게 경제적 장벽이 되어 시장의 성장과 접근성을 제한하고 있습니다.

입자선 치료 시장에 영향을 미치는 요인에는 성장 궤도를 결정하는 시장 성장 촉진요인 및 과제가 있습니다. 기술 발전, 암 발병률 증가, 정부 지원이 이 산업을 촉진하고 있지만, 높은 비용, 제한된 가용성, 특정 규제는 여전히 과제로 남아 있습니다. 입자선 치료 산업이 계속 번영하기 위해서는 이러한 장애물을 극복하고 이 분야의 추가 성장을 가능하게 하는 방법을 찾아야 합니다.

목차

제1장 주요 요약

제2장 세계의 입자선 치료 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019년-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 입자선 치료 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 입자선 치료 시장 : 유형별
  • 양자선 치료
  • 중립자선 치료
• 세계의 입자선 치료 시장 : 암 유형별
  • 소아암
  • 폐암
  • 유방암
  • 두부암
  • 기타
• 세계의 입자선 치료 시장 : 시스템별
  • 멀티 룸 시스템
  • 싱글 룸 시스템
• 세계의 입자선 치료 시장 : 용도별
  • 치료
  • 연구
  • 기타

제4장 지역별 시장 동향과 예측 분석(2019년-2031년)

• 세계의 입자선 치료 시장 : 지역별
• 북미의 입자선 치료 시장
• 유럽의 입자선 치료 시장
• 아시아태평양의 입자선 치료 시장
• 기타 지역의 입자선 치료 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 입자선 치료 시장 성장 기회 : 유형별
  • 세계의 입자선 치료 시장 성장 기회 : 암 유형별
  • 세계의 입자선 치료 시장 성장 기회 : 시스템별
  • 세계의 입자선 치료 시장 성장 기회 : 용도별
  • 세계의 입자선 치료 시장 성장 기회 : 지역별
• 세계의 입자선 치료 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 입자선 치료 시장 생산능력 확대
  • 세계의 입자선 치료 시장 기업인수합병(M&A), 합병사업
  • 인증 및 라이선싱

제7장 주요 기업 개요

• IBA Worldwide
• Varian Medical Systems
• Hitachi
• Mevion Medical Systems
• Sumitomo Heavy Industries
• Provision Healthcare
• Toshiba Medical Systems
• Optivus Proton Therapy
• Protom International
• Advanced Oncotherapy

영문목차

The future of the global particle therapy market looks promising with opportunities in the treatment and research markets. The global particle therapy market is expected to reach an estimated $1.3 billion by 2031 with a CAGR of 7.8% from 2025 to 2031. The major drivers for this market are the escalating incidence of cancer, the surging embrace of particle therapy in clinical research, and the rising count of particle therapy facilities globally.

• Lucintel forecasts that, within the type category, proton is expected to witness the highest growth over the forecast period.
• Within the application category, treatment is expected to witness the highest growth over the forecast period.
• In terms of regions, North America will remain the largest region over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Particle Therapy Market

Particle therapy as a market has been changing rapidly due to technology, global collaboration, and the need for better ways of treating cancer. These emerging trends are influencing the direction of this market, thereby creating new opportunities for growth and innovation. Such trends are leading to more accessible, efficient, and patient-centered therapies that will continue driving the market.

• Technological Innovation: Technological advancements in particle therapy, such as pencil beam scanning and adaptive therapy, are improving precision and outcomes. Furthermore, these innovations have reduced treatment times along with side effects, making particle therapy more attractive to both caregivers and patients. This creates room for more effective treatment options, hence driving the market through improved imaging as well as delivery systems.
• Expansion in Emerging Markets: Particle therapy is growing fast in emerging markets, especially in Asia. China and India, for instance, are witnessing high growth rates due to the increasing number of cancer cases coupled with huge investments in the healthcare sector. This expansion enables more people from different areas, including those who live far from city centers, to access this mode of care, thus leading to increased worldwide acceptance of particle therapy by large population groups and becoming a dynamic factor behind global market expansion.
• Integrating with AI and Big Data: Understanding this, the integration of particle therapy with AI and big data is revolutionizing its treatment planning as well as outcomes. For instance, AI can be deployed to optimize treatment plans, increase accuracy, and predict patient responses. The application of big data in medicine is making it possible for personalized treatment to become a reality, which in turn has improved patients' well-being. As a result, this trend continues to transform particle therapy into an even more precise and efficient mode of treatment.
• Increased Public and Private Funding: As such, there is increased funding from both public sources and private investors that is driving research on particle therapy (PT). Governments and other stakeholders have realized the potential of PT in cancer treatment, thereby leading to more grants, partnerships, and investments. This financial infusion is fostering global innovation through the establishment of novel particle therapy centers.
• Growing Focus on Patient-Centric Care: There are growing calls for patient-centric care in the particle therapy market aimed at improving patient experience and outcome enhancement measures being given priority over others. This implies that more user-friendly treatments can be developed, including better supportive care services. This trend paves the way for the invention of much easier approaches toward managing illnesses involving protons, thus boosting global effectiveness levels among different stakeholders involved within the PT ecosystem.

The particle therapy market is going through significant changes due to emerging trends that enhance innovation, expand access, and improve the quality of patients' lives. Due to these developments, ongoing adaptation will lead to further recognition of particle therapy as a key element in cancer management and control, which makes it the backbone of modern oncology.

Recent Developments in the Particle Therapy Market

The rise in importance witnessed within the particle therapy market has led to several major developments taking place worldwide which are characterized by technological advancements, strategic alliances; and increased investments all aimed at enhancing the market's potential and making it more accessible.

• Advances in Proton Therapy: Recently, the modernization of proton therapy has seen its treatment precision being improved along with patients' outcomes. These new advancements have introduced advanced technologies such as intensity-modulated proton therapy (IMPT) and pencil beam scanning which lead to reduced side effects during treatment. This development has led to the emergence of proton therapy centers globally thereby extending particle therapy reach.
• Strategic Collaborations and Partnerships: Innovations within Particle Therapy are being driven by strategic alliances between healthcare providers, research institutions, and technology companies. Such collaborations are responsible for the birth of novel treatment protocols, and technological advancements that enable improved delivery systems among others. This movement is expediting the growth of PT market through its abilities improvement plus facilities accessibility.
• Expansion of Particle Therapy Centers: The global expansion of Particle Therapy centers, particularly in emerging markets, is a significant development in the market. A number of these countries such as China and India are increasingly setting up more centers due to growing rates of cancer victims coupled with rising healthcare investments. This demographic expansion allows more individuals to access Particle Therapy hence leading to market growth.
• Increased Government Support and Funding: Governments globally are supporting increased funding for particle therapy due to its potential in treating cancer. These funds come in form grants, subsidies and favorable policies that promote research as well as establishment of new therapeutic centers. Consequently this move is instrumental in advancing the market thus making PT available globally for all who need it most.
• Integrating Advanced Imaging Techniques: The integration of advanced imaging techniques like MRI and CT into Particle Therapy is improving treatment accuracy and prognosis. These scanning technologies allow for improved tumor visibility and more precise planning for treatments leading to better care for patients. Thus, this development is making Particle Therapy a more viable choice by increasing its efficacy and dependability.

Thus, these developments are significantly impacting the particle therapy market through technological innovation, increased accessibility as well as government and private sector support towards the course. In the future, such trends will amplify Particle Therapy's position in cancer treatment hence being included in modern oncology as one of the most important factors.

Strategic Growth Opportunities for Particle Therapy Market

The particle therapy market has several applications that would serve as strategic growth opportunities. These include advancements in technology, an increase in cancer incidences, and the need to have better treatment alternatives. It is therefore important to focus on these areas for significant market expansion while at the same time improving patient outcomes.

• Pediatric Cancer Treatment: One of the fastest-growing sectors within particle therapy is pediatric cancer treatment. In children especially proton therapy provides highly accurate results with minimal side effects being observed. Thereby, there has been an increase in demand for pediatric oriented centers offering various forms of particle treatments due to increased awareness and presence of radiation facilities. This opportunity drives investments into child friendly protocols researches on new ways of treating children with cancers.
• Head and Neck Cancer Treatment: Head and neck cancers represent a major growth area for particle therapy. Owing to their proximity to sensitive organs like the spinal cord or brain, these cancers require a lot of precision during the treatment process. In such cases where tissues around do not suffer from much damage, particle therapy presents itself as the perfect approach because it is targeted at specific body parts only. Consequently, head and neck cancers increasingly call for specialized particle therapies.
• Recurrent Cancer Treatment: Particle Therapy is very promising in recurrent cancer treatment. Patients with recurrent tumors often have limited treatment options due to previous radiation exposure. Particle therapy has been seen as a safe option that only affects the tumor while sparing the surrounding healthy tissue. Thus, this feature is driving up its adoption in cases of relapse cancers presenting an opportunity for strategic growth in this market.
• Integration with Immunotherapy: Combining particle therapy and immunotherapy represents an emerging field of development in cancer treatment. This combination can significantly enhance immune response to the tumor resulting in better outcomes. Research works are ongoing with clinical testing being done on synergistic effects between Particle Therapy and immunotherapies suggesting further development interest inside the market sector. Therefore, such fusion becomes an excellent chance to generate new types of cancer drugs and expand particle therapy into more markets.
• Lung Cancer Treatment: When it comes to lung cancer treatment, particle therapy is gaining attention partly because it is a very difficult region to deal with tumors. It remains one of the best options because it provides accurate radon doses without harming other parts of lung tissue thus minimizing side effects associated with this disease process. Additionally, rising global statistics regarding lung cancer incidences have called for advanced interventions by positioning them among key areas expected to grow within this market segment.

The future of the particle therapy market is being forged by these strategic growth opportunities which address critical needs in cancer treatment. By focusing on these applications, the market can widen its scope and improve patient outcomes thus making Particle Therapy a cornerstone of modern oncology.

Particle Therapy Market Driver and Challenges

The particle therapy market is influenced by several factors including technological advances, economic considerations, and regulatory challenges. These have significant implications for market growth as well as the provision of effective cancer treatments. To sail through a dynamic landscape of Particle Therapy, stakeholders need to understand such drivers and challenges.

The factors responsible for driving the particle therapy market include:

1. Technological Developments: Key drivers in terms of particle therapy include technological advancements like pencil beam scanning and adaptive therapy. These developments enhance treatment precision while minimizing side effects which leads to better therapeutic success rates. Thus, it is anticipated that with time technology will continue to drive the adoption of particle therapy to become a favored option in the treatment of cancer worldwide.

2. Increasing Cancer Incidence: A major driver for the particle therapy market has been the rising incidence of global cancer cases. As new cases continue to occur there are demands for advanced treatments that work better. This has led to an increasing acceptance globally regarding particle therapy as a better form of treatment for various types of cancers which has driven this trajectory.

3. Government Support and Funding: Government support and funding are important drivers behind the development of particle therapy markets. Governments invest in developing particle facilities alongside providing research grants. The importance cannot be understated because it promotes affordability and increases access hence expanding this particular industry allowing more patients to benefit from this technology.

4. Growing Awareness and Adoption: Increasing awareness about advantages related with particle therapy is boosting its use throughout different parts around the globe. Both patients and providers have learned more regarding these benefits compared to existing radiation technologies resulting in increased demand for particles centers driving growth within this market.

5. Expansion in Emerging Markets: One of the driving forces for the global particle therapy market is its expansion in emerging markets, specifically in Asia. Particle therapy has been rapidly taken up by countries such as China and India due to rising cancer cases and growing healthcare spending. The result is an expanded accessibility that has enabled more people to enjoy its benefits thereby making it a global phenomenon.

Challenges in the particle therapy market are:

1. High Costs of Treatment: High cost of treatment is one major challenge facing the particle therapy market. Costly machinery and other facilities tied to particle therapy make it unaffordable for many patients especially those from low income communities. This difficulty poses a significant impediment to widespread adoption of this technology hence limiting its growth prospects in the market.

2. Limited Availability of Facilities: Another key challenge is limited access to particle therapy centers. These centers are increasing in numbers but they are still scarce compared with demand. As a consequence, many patients particularly those living in rural or under-served areas cannot access particle therapy because there inadequate facilities available, hampering firms' ability to penetrate new markets which would enhance their growth.

3. Regulation and Reimbursement Issues: The particle therapy market faces obstacles from regulatory and reimbursement issues. The intricate rules and regulations of different countries and divergent policies regarding reimbursement lead to delays in the adoption of new technologies. These challenges also create financial barriers to patients, thereby limiting market growth and accessibility.

Factors affecting the particle therapy market include drivers and challenges that determine its growth trajectory. Technological advancements, rising cancer incidence, and government support are propelling this industry but high costs, limited availability as well as certain regulation remains a challenge. For the Particle Therapy industry to continue thriving it must find ways of overcoming these obstacles to enable the sector to grow further.

List of Particle Therapy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies particle therapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the particle therapy companies profiled in this report include-

• IBA Worldwide
• Varian Medical Systems
• Hitachi
• Mevion Medical Systems
• Sumitomo Heavy Industries
• Provision Healthcare
• Toshiba Medical Systems
• Optivus Proton Therapy
• Protom International
• Advanced Oncotherapy

Particle Therapy by Segment

The study includes a forecast for the global particle therapy market by type, cancer type, system, application, and region.

Particle Therapy Market by Type [Analysis by Value from 2019 to 2031]:

• Proton Therapy
• Heavy-Ion Therapy

Particle Therapy Market by Cancer Type [Analysis by Value from 2019 to 2031]:

• Pediatric Cancer
• Lung Cancer
• Breast Cancer
• Head Cancer
• Others

Particle Therapy Market by System [Analysis by Value from 2019 to 2031]:

• Multi-Room Systems
• Single-Room Systems

Particle Therapy Market by Application [Analysis by Value from 2019 to 2031]:

• Treatment
• Research
• Others

Particle Therapy Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Particle Therapy Market

The particle therapy market is experiencing significant growth driven by technological advances and the growing adoption of cancer treatment worldwide. The U.S., China, Germany, India, and Japan have made notable developments indicating their commitment to innovative therapies aimed at improving cancer care. These developments reflect both regional strategies and global trends that will shape the future of particle therapy.

• United States: Particle therapy centers in the U.S. are rapidly growing due to the demand for precision treatments for cancer. Institutions like the Mayo Clinic and MD Anderson Cancer Center have increased spending on proton therapy facilities. This has positioned the U.S. as a leader in technology and clinical trials involving particle therapy globally, supported by grants from the U.S. government and research initiatives.
• China: China has made significant strides in particle therapy by establishing multiple proton therapy centers backed by strong government support. The rising incidence of cancers among the Chinese population, coupled with a focus on healthcare reform, has necessitated this expansion. As a result, many Chinese companies are collaborating with international leaders to enhance their technological capabilities, positioning China as a major player in the particle therapy market.
• Germany: Germany continues to lead in European particle therapy, with increasing breakthroughs in proton and heavy ion therapy. The country's advanced medical infrastructure, supported by a robust research and development culture, has led to the establishment of modern facilities. Furthermore, Germany's integration of particle therapy into its public health policies further confirms its premier position globally.
• India: Particle therapy adoption has surged in India due to a high burden of cancer, coupled with improved healthcare infrastructure. More centers are being planned and established, given the government support and increased awareness, making India a growing hub for advanced cancer treatment.
• Japan: Proton and heavy ion therapies dominate Japan's already mature particle therapy market, driven by patient-centered innovations resulting in world-class facilities. Known for its "Industry-Academia-Government Collaboration," these partnerships have nurtured Japan's continuous development, allowing it to remain at the forefront of the global particle therapy market.

Features of the Global Particle Therapy Market

Market Size Estimates: Particle therapy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Particle therapy market size by various segments, such as by type, cancer type, system, application, and region in terms of value ($B).

Regional Analysis: Particle therapy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, cancer types, systems, applications, and regions for the particle therapy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the particle therapy market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the particle therapy market by type (proton therapy and heavy-ion therapy), cancer type (pediatric cancer, lung cancer, breast cancer, head cancer, and others), system (multi-room systems and single-room systems), application (treatment, research, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Particle Therapy Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Particle Therapy Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Particle Therapy Market by Type
  • 3.3.1: Proton Therapy
  • 3.3.2: Heavy-Ion Therapy
• 3.4: Global Particle Therapy Market by Cancer Type
  • 3.4.1: Pediatric Cancer
  • 3.4.2: Lung Cancer
  • 3.4.3: Breast Cancer
  • 3.4.4: Head Cancer
  • 3.4.5: Others
• 3.5: Global Particle Therapy Market by System
  • 3.5.1: Multi-Room Systems
  • 3.5.2: Single-Room Systems
• 3.6: Global Particle Therapy Market by Application
  • 3.6.1: Treatment
  • 3.6.2: Research
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Particle Therapy Market by Region
• 4.2: North American Particle Therapy Market
  • 4.2.1: North American Market by Type: Proton Therapy and Heavy-Ion Therapy
  • 4.2.2: North American Market by Application: Treatment, Research, and Others
• 4.3: European Particle Therapy Market
  • 4.3.1: European Market by Type: Proton Therapy and Heavy-Ion Therapy
  • 4.3.2: European Market by Application: Treatment, Research, and Others
• 4.4: APAC Particle Therapy Market
  • 4.4.1: APAC Market by Type: Proton Therapy and Heavy-Ion Therapy
  • 4.4.2: APAC Market by Application: Treatment, Research, and Others
• 4.5: ROW Particle Therapy Market
  • 4.5.1: ROW Market by Type: Proton Therapy and Heavy-Ion Therapy
  • 4.5.2: ROW Market by Application: Treatment, Research, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Particle Therapy Market by Type
  • 6.1.2: Growth Opportunities for the Global Particle Therapy Market by Cancer Type
  • 6.1.3: Growth Opportunities for the Global Particle Therapy Market by System
  • 6.1.4: Growth Opportunities for the Global Particle Therapy Market by Application
  • 6.1.5: Growth Opportunities for the Global Particle Therapy Market by Region
• 6.2: Emerging Trends in the Global Particle Therapy Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Particle Therapy Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Particle Therapy Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: IBA Worldwide
• 7.2: Varian Medical Systems
• 7.3: Hitachi
• 7.4: Mevion Medical Systems
• 7.5: Sumitomo Heavy Industries
• 7.6: Provision Healthcare
• 7.7: Toshiba Medical Systems
• 7.8: Optivus Proton Therapy
• 7.9: Protom International
• 7.10: Advanced Oncotherapy